Moderna Inc. Common Stock (MRNA)

About MRNA

Moderna, Inc., a biotechnology company, provides messenger RNA medicines in the United States, Europe, and internationally. The company's respiratory vaccines include spikevax, mNEXSPIKE, mRESVIA, COVID, RSV, seasonal influenza, combination, and pandemic influenza vaccine; latent vaccines comprise cytomegalovirus, epstein-barr virus, and human immunodeficiency virus vaccines; enteric viruses include norovirus; public…

Sector

Health Care

Industry

Biotechnology: Biological Products (No Diagnostic Substances)

Employees

4,700

Website

www.modernatx.com/

Fundamentals

1-day range

$133.33$138.8

Market cap

$21.88B

P/E (trailing)

—

P/E (forward)

-29.75

EPS (trailing)

$-7.98

Dividend yield

—

Beta

1.17

Avg. volume

14.82M

Forecasts

16 analyst ratings

Moderna Inc. Common Stock Competitors

Chosen by industry and closest market cap.

• MRNA

  Moderna Inc. Common Stock

  $137.93

  ▼ 3.39%
  Market cap $21.88BP/E —
  $22.28$176.66
• BNTX

  BioNTech SE American Depositary Share

  $102.04

  ▼ 8.40%
  Market cap $23.18BP/E —
  $79.52$124
• HALO

  Halozyme Therapeutics Inc. Common Stock

  $105.33

  ▼ 1.49%
  Market cap $9.76BP/E 27.63
  $61.23$109.66
• QGEN

  Qiagen N.V. Common Shares

  $43.12

  ▼ 1.43%
  Market cap $8.72BP/E 22.14
  $32.53$57.82
• KYMR

  Kymera Therapeutics Inc. Common Stock

  $118.08

  ▼ 1.79%
  Market cap $8.25BP/E —
  $39.84$130.05
• RVMD

  Revolution Medicines Inc. Common Stock

  $207.89

  ▼ 6.00%
  Market cap $38.79BP/E —
  $35.64$224.31
• CRSP

  CRISPR Therapeutics AG Common Shares

  $57.69

  ▼ 2.84%
  Market cap $4.78BP/E —
  $44.12$78.48

P/E shows — for peers not currently carrying a live signal of their own.

Latest news

• BioNTech: Reiterating Strong Buy Based On COMIRNATY Variant Expansion And More
  SeekingAlpha · 8/28/2026
• What's going on in today's session: S&P500 gap up and gap down stocks
  ChartMill · 8/28/2026
• World Health Organization Director General Determined That The Ebola Epidemic In DRC Still Meets Criteria Of Public Health Emergency Of International Concern, But Not Those Of A Pandemic Emergency
  Benzinga · 8/28/2026
• This Moderna Analyst Turns Bullish; Here Are Top 3 Upgrades For Friday
  Benzinga · 8/28/2026
• Moderna Stock Falls Friday: What's Going On?
  Benzinga · 8/28/2026
• Argus Research Upgrades Moderna to Buy, Announces $180 Price Target
  Benzinga · 8/28/2026
• What's going on in today's session: S&P500 movers
  ChartMill · 8/27/2026
• QUICK SPARK: FDA Approves Updated COVID Vaccines From Moderna, Pfizer, Novavax
  Benzinga · 8/27/2026
• Bessent's Bond Band-Aid, Bitcoin's Best Week Since 2023: This Week on Wall Street
  benzinga · 8/21/2026

• Stephane Bancel · August 6, 2026 · Option Exercise

  64.9K
• Stephane Bancel · August 6, 2026 · Option Exercise

  187.5K
• Stephane Bancel · August 6, 2026 · Option Exercise

  252.5K @ $19.15
• Stephane Bancel · August 5, 2026 · Option Exercise

  128.4K
• Stephane Bancel · August 5, 2026 · Option Exercise

  370.9K
• Stephane Bancel · August 5, 2026 · Sale

  187.0K @ $58.79
• Stephane Bancel · August 5, 2026 · Sale

  39.9K @ $58.12
• Stephane Bancel · August 5, 2026 · Sale

  124.8K @ $56.96
• Stephane Bancel · August 5, 2026 · Sale

  147.5K @ $56.21
• Stephane Bancel · August 5, 2026 · Option Exercise

  499.2K @ $19.15
• Stephen Hoge · July 15, 2026 · Option Exercise

  16.1K @ $19.15
• Stephen Hoge · July 15, 2026 · Option Exercise

  37.2K @ $19.15
• Stephen Hoge · July 15, 2026 · Sale

  53.3K @ $67.6
• Michael R. McDonnell · July 8, 2026 · Grant

  5.7K
• Michael R. McDonnell · July 8, 2026 · Grant

  1.6K

Institutional Ownership

March 31, 2026

Total shares held

348.76M

Total value held

$17.55B

Institutional holders

722